ABCB1 and breast cancer: Study on mouse model for BRCA-deficient breast cancer revealed that olaparib resistance was driven by up-regulation of Abcb1a/b genes encoding P-glycoprotein and could be reversed by inhibition of P-glycoprotein [4].